Janus Henderson Group
BNGO icon

Janus Henderson Group’s Bionano Genomics BNGO Stock Holding History

Janus Henderson Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-211
Closed -$140K – 2604
2023
Q1 		$140K Buy
211
+117
+124% +$104K ﹤0.01% 2572
2022
Q4 		$82.4K Sell
94
-95
-50% -$120K ﹤0.01% 2362
2022
Q3 		$208K Buy
189
+95
+101% +$126K ﹤0.01% 2391
2022
Q2 		$78K Hold
94
– – ﹤0.01% 2509
2022
Q1 		$146K Hold
94
– – ﹤0.01% 2505
2021
Q4 		$169K Buy
94
+47
+100% +$126K ﹤0.01% 2436
2021
Q3 		$155K Buy
+47
New +$164K ﹤0.01% 2107

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group's BNGO Position: Q2 2023 in Review

Janus Henderson Group sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 211 shares — an estimated $140K sold.

Janus Henderson Group first reported a position in BNGO in Q3 2021 and held it in 7 quarters. The position peaked at $208K in Q3 2022. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Janus Henderson Group reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Janus Henderson Group sold 211 Bionano Genomics shares in Q2 2023, an estimated $140K.
  • Janus Henderson Group first reported a position in Bionano Genomics in Q3 2021 and held it in 7 quarters.
  • Janus Henderson Group's Bionano Genomics position peaked at $208K in Q3 2022.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.